LiLF, LiuG, WangJ. Prevalence and 1-year outcome of facial allergic contact dermatitis in patients patch tested in a university hospital. Contact Dermatitis, 2007; 57(3):187–190.
2.
WarshawEM, SchlarbaumJP, MaibachHI, et al.Facial dermatitis in male patients referred for patch testing: Retrospective analysis of North American Contact Dermatitis Group data, 1994 to 2016. JAMA Dermatol, 2020; 156(1):79–84.
3.
HortonE, UterW, GeierJ, et al.Developing a cosmetic series: Results from the ESSCA network, 2009-2018. Contact Dermatitis, 2021; 84(2):82–94.
4.
LiLF, WangJ. Patch testing and aeroallergen intradermal testing in facial dermatitis. Contact Dermatitis, 2000; 43(2):90–94.
5.
NiC, DouX, ChenJ, et al.Contact sensitization in Chinese patients with hand eczema. Dermatitis, 2011; 22(4):211–215.
6.
OosterhavenJAF, UterW, AbererW, et al.European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis. Contact Dermatitis, 2019; 80(5):263–272.
7.
IsakssonM, AleI, AndersenKE, et al.Multicenter patch testing with methylisothiazolinone and methylchloroisothiazolinone/methylisothiazolinone within the international contact dermatitis research group. Dermatitis, 2017; 28(3):210–214.
8.
AudicanaMT, MuñozD, del PozoMD, et al.Allergic contact dermatitis from mercury antiseptics and derivatives: Study protocol of tolerance to intramuscular injections of thimerosal. Am J Contact Dermat, 2002; 13(1):3–9.
